Literature DB >> 10816175

[Clinical practice guidelines of the Spanish Society of Cardiology for physical activity in patients with cardiac disease].

A Boraita Pérez1, A Baño Rodrigo, J R Berrazueta Fernández, R Lamiel Alcaine, E Luengo Fernández, P Manonelles Marqueta, C Pons I de Beristain.   

Abstract

This chapter includes general recommendations regarding the eligibility for recreational and competitive sports participation. Although based on the latest knowledge in sports medicine and cardiology, these recommendations should be updated according to advances in the understanding of the athlete's heart. Physical exercise plays an important role in the leisure time of our society. Many patients with cardiac disease don't want to give up their physical or sport activity programs. Moreover, there is no doubt that many cardiovascular abnormalities may benefit from a controlled physical exercise program. Understanding the cardiac adaptations to exercise training, individualised evaluation of each cardiac pathology and adequate exercise prescription is essential in order to minimize the risks for every cardiac patient.

Entities:  

Mesh:

Year:  2000        PMID: 10816175

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  2 in total

Review 1.  Cardiac risk stratification in cardiac rehabilitation programs: a review of protocols.

Authors:  Anne Kastelianne França da Silva; Marianne Penachini da Costa de Rezende Barbosa; Aline Fernanda Barbosa Bernardo; Franciele Marques Vanderlei; Francis Lopes Pacagnelli; Luiz Carlos Marques Vanderlei
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Apr-Jun

2.  Effectiveness and safety of a home-based cardiac rehabilitation programme of mixed surveillance in patients with ischemic heart disease at moderate cardiovascular risk: A randomised, controlled clinical trial.

Authors:  Raquel Bravo-Escobar; Alicia González-Represas; Adela María Gómez-González; Angel Montiel-Trujillo; Rafael Aguilar-Jimenez; Rosa Carrasco-Ruíz; Pablo Salinas-Sánchez
Journal:  BMC Cardiovasc Disord       Date:  2017-02-20       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.